Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes

Colloids and Surfaces B: Biointerfaces

Volumn 121, Issue , 2014, Pages 461-468

  Pooja, Deep ^a,b   Kulhari, Hitesh ^a,c   Singh, Mayank K ^a   Mukherjee, Sudip ^a   Rachamalla, Shyam Sunder ^b   Sistla, Ramakrishna ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b OSMANIA UNIVERSITY   (India)

^c RMIT UNIVERSITY   (Australia)

Author keywords

Mixed micelles; Poly(amidoamine) dendrimers; Solubility; Taxanes; TPGS

Indexed keywords

BIOCOMPATIBILITY; CELLS; CYTOTOXICITY; DENDRIMERS; DRUG PRODUCTS; SOLUBILITY; TOXICITY;

ANTICANCER ACTIVITIES; MIXED MICELLES; POLYAMIDOAMINE DENDRIMERS; POORLY WATER-SOLUBLE DRUGS; SOLUBILITY ENHANCEMENT; SOLVENT CASTING METHOD; TAXANES; TPGS; CELLULAR TOXICITIES;

MICELLES; SOLUBILITY;

DENDRIMER; DEXTRO ALPHA TOCOPHEROL POLYETHYLENE GLYCOL SUCCINATE; DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; SOLVENT; UNCLASSIFIED DRUG; ALPHA TOCOPHEROL; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; MACROGOL DERIVATIVE; MICELLE; TAXOID; ALPHA TOCOPHEROL POLYETHYLENE GLYCOL SUCCINATE; TAXANE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CHO CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LUNG CANCER; MCF 7 CELL LINE; MICELLE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; X RAY DIFFRACTION; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CELL DEATH; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; RAT; SOLUBILITY; STATIC ELECTRICITY; SYNTHESIS; A549 CELL LINE; ANALYTIC METHOD; BIOASSAY; BIOCOMPATIBILITY; BREAST CANCER CELL LINE; CELL PROLIFERATION ASSAY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; DYNAMIC LIGHT SCATTERING TECHNIQUE; HEMOLYTIC TOXICITY ASSAY; LUNG CANCER CELL LINE; MTT ASSAY; NANOMICELLE; NANOTECHNOLOGY; POWDER X RAY DIFFRACTION ANALYSIS;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; DENDRIMERS; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; MICELLES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; TAXOIDS; VITAMIN E; X-RAY DIFFRACTION;

EID: 84905443227     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.06.059     Document Type: Article

References (39)

1. Ringel S.B., Horwitz J. Nat. Cancer Inst. 1991, 83:288-291.
2. Horwitz S.B. Trends Pharmacol. Sci. 1992, 13:134-136.
3. Goodman & Gilman's: The Pharmacological Basis of Therapeutics 1996, McGraw-Hill Companies Health Professions Division, New York, NY. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.).
4. Hamada H., Ishihara K., Masuoka N., Milkuni K., Nakajima N. J. Biosci. Bioeng. 2006, 102:369-371.
5. Mathew A.E., Mejillano M.R., Nath J.P., Himes R.H., Stella V.J. J. Med. Chem. 1992, 35:145-451.
6. Du W., Hong L., Yao T., Yang X., He Q., Yang B., Hu Y. Bioorg. Med. Chem. 2007, 15:6326-6330.
7. Ali S.M., Hoemann M.Z., Aube J., Georg G.I., Mitcher L.A., Jayasinghe L.R. J. Med. Chem. 1997, 40:236-241.
8. Zaske L., Perrin M.A., Leveiller F. J. Phys. IV 2001, 11:221-226.
9. Taxol* (Paclitaxel) Injection, Bristol-Myers Squibb, Princeton (2011) 1-53.
10. Weiss R.B., Donehower R.C., Wiernik P.H., Ohnuma T., Gralla R.J., Trump D.L., Baker J.R., Van Eho D.A., Von Hoff D.D., Leyland-Jones B. J. Clin. Oncol. 1990, 8:1263-1268.
11. Ellis A.G., Crinis N.A., Webster L.K. Cancer Chemother. Pharmacol. 1996, 38:81-87.
12. Loos W.J., Baker S.D., Verweij J., Boonstra J.G., Sparreboom A. Clin. Pharmacol. Ther. 2003, 74:364-371.
13. Bissery M., Renard A., Andre S., et al. Ann. Oncol. 1992, 3:121.
14. Marupudi N.I., Han L.I.K.W., Renard V.M., Tyler B.M., Brem H. Expert Opin. Drug Saf. 2007, 6:609-621.
15. Sharma A., Mayhew E., Bolcsak L., Cavanaugh C., Harmon P., Janoff A., Bernacki R.J. Int. J. Cancer 1997, 71:103-107.
16. Sharma A., Sharma U.S., Straubinger R.M. Cancer Lett. 1996, 107:265-272.
17. Cabanes A., Briggs K.E., Gokhale P.C., Treat J.A., Rahman A. Int. J. Oncol. 1998, 12:1035-1040.
18. Kulhari H., Pooja Deep, Prajapati S.K., Chauhan A.S. Int. J. Pharm. 2011, 405:203-209.
19. Solons P.I.C., Nolla J., Azemar N., Garcia-Celma M.J. Curr. Opin. Colloid Interface Sci. 2005, 10:102-110.
20. Muller R.H., Mader K., Gohla S. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
21. Muhlen A.Z., Schwarz C., Mehnert W. Eur. J. Pharm. Biopharm. 1998, 45:149-155.
22. Muller R.H., Ruhl D., Runge S., SchulzeForster K., Mehnert W. Pharm. Res. 1997, 14:458-462.
23. Muller R.H., Maassen S., Weyhers H., Specht F., Lucks J.S. Int. J. Pharm. 1996, 138:85-94.
24. van Schooneveld M.M., Vucic E., Koole R., Zhou Y., Stocks J., Cormode D.P., Tang C.Y., Gordon R.E., Nicolay K., Meijerink A., Fayad Z.A., Mulder W.J. Nano Lett. 2008, 8:2517-2525.
25. Kulhari H., Pooja Deep, Singh M.K., Chauhan A.S. Drug Dev. Ind. Pharm. 2013, doi: 10.3109/03639045.2013.858735.
26. Chauhan A.S., Jain N.K., Diwan P.V., Khopade A.J. J. Drug Targeting 2004, 12:575-583.
27. Prajapati R.N., Tekade R.K., Gupta U., Gajbhiye U., Jain N.K. Mol. Pharm. 2009, 6:940-950.
28. Jain N.K., Prajapati R.N., Agarwal A., Gupta U., Asthana A. Asian J. Pharm. 2009, 3:188-196.
29. Kulhari H., Kulhari D.P., Prajapati S.K., Chauhan A.S. Mol. Pharm. 2013, 10:2528-2533.
30. Fisher J.R., Harkin K.R., Freeman L.C. Vet. Ther. Res. Appl. Vet. Med. 2002, 3:465-473.
31. Dintaman J.M., Silverman J.A. Pharm. Res. 1999, 16:1550-1556.
32. Youk H.J., Lee E., Chou M.K., Lee Y.J., Chung J.H., Kim S.H., Lee C.H., Lim S.J. J. Controlled Release 2005, 107:53-69.
33. Varma M.V.S., Panchagnula R. Eur. J. Pharm. Sci. 2005, 25:445-453.
34. Collnot E.M., Baldes C., Schafer U.F., Edgar K.J., Wempe M.F., Lehr C.M. Mol. Pharm. 2010, 7:642-651.
35. Constantinides P.P., Han J.H., Davsis S.S. Pharm. Res. 2006, 23:243-255.
36. Torchilin V.P. Pharm. Res. 2007, 24:1-16.
37. Gupta U., Agashe H.B., Asthana A., Jain N.K. Biomacromolecules 2006, 7:649-658.
38. Liu M., Kono K., Frechet J.M. J. Controlled Release 2000, 65:121.
39. Bildstein L., Dubernet C., Couvreur P. Adv. Drug Delivery Rev. 2011, 63:3-23.